Abstract:Circulation Research, Ahead of Print. BACKGROUND:Andersen-Tawil syndrome type 1 is a rare heritable disease caused by mutations in the gene coding the strong inwardly rectifying K+channel Kir2.1. The extracellular Cys (cysteine)122-to-Cys154disulfide bond in the channel structure is crucial for proper folding but has not been associated with correct channel function at the membrane. We evaluated whether a human mutation at the Cys122-to-Cys154disulfide bridge leads to Kir2.1 channel dysfunction and arrhythmias by reorganizing the overall Kir2.1 channel structure and destabilizing its open state.METHODS AND RESULTS:We identified a Kir2.1 loss-of-function Cys122mutation (c.366 A>T; p.Cys122Tyr) in an Andersen-Tawil syndrome type 1 family. We generated a cardiac-specific mouse model expressing the Kir2.1C122Ythat recapitulated the abnormal ECG features of Andersen-Tawil syndrome type 1 independently of sex, including corrected QT prolongation, conduction defects, and increased arrhythmia susceptibility. Isolated Kir2.1C122Ycardiomyocytes showed significantly reduced inwardly rectifier K+(IK1) and inward Na+(INa) current densities independently of normal trafficking to and localization at the sarcolemma and the sarcoplasmic reticulum. However, molecular dynamics predicted that the C122Y mutation provoked a conformational change over the 2000-ns simulation, characterized by a greater loss of hydrogen bonds between Kir2.1 and phosphatidylinositol 4,5-bisphosphate than WT. Therefore, the phosphatidylinositol 4,5-bisphosphate–binding pocket was destabilized, resulting in a lower conductance state compared with WT. Accordingly, on inside-out patch clamping, the C122Y mutation significantly blunted Kir2.1 sensitivity to increasing phosphatidylinositol 4,5-bisphosphate concentrations. In addition, the Kir2.1C122Ymutation resulted in channelosome degradation, demonstrating temporal instability of both Kir2.1 and NaV1.5 proteins.CONCLUSIONS:The extracellular Cys122-to-Cys154disulfide bond in the tridimensional Kir2.1 channel structure is essential for the channel function. We demonstrate that breaking disulfide bonds in the extracellular domain disrupts phosphatidylinositol 4,5-bisphosphate–dependent regulation, leading to channel dysfunction and defects in Kir2.1 energetic stability. The mutation also alters functional expression of the NaV1.5 channel and ultimately leads to conduction disturbances and life-threatening arrhythmia characteristic of Andersen-Tawil syndrome type 1.

KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia

Characterization of a Novel Mutation in the Cardiac Ryanodine Receptor That Results in Catecholaminergic Polymorphic Ventricular Tachycardia

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

A Kir2.1 Gain-of-function Mutation Underlies Familial Atrial Fibrillation.

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome

Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events

Characterization of a Novel, Dominant Negative KCNJ2 Mutation Associated with Andersen-Tawil Syndrome.

Mutations In Cytoplasmic Loops Of The Kcnq1 Channel And The Risk Of Life-Threatening Events Implications For Mutation-Specific Response To Beta-Blocker Therapy In Type 1 Long-Qt Syndrome

A Molecular Mechanism for Adrenergic-Induced Long QT Syndrome.

SA126CELL TYPE-SPECIFIC ALTERNATION IN SCHIZOPHRENIA AND BIPOLAR DISORDER

Electrophysiological Characteristics of the LQT2 Syndrome Mutation KCNH2-G572S and Regulation by Accessory Protein KCNE2

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Atomic-Level Investigation of KCNJ2 Mutations Associated with Ventricular Arrhythmic Syndrome Phenotypes

Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome

A Weak Dominant Negative Mutation of KCNQ1-G269S Affects PKA-Mediated Up-Regulation of IKs Channels and Causes Adrenergic Triggered Long QT Syndrome

The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2

[Identification and Functional Analysis of a KCNA5 Mutation Responsible for Idiopathic Atrial Fibrillation].